A Study of LY2880070 and Gemcitabine in People With Ewing Sarcoma or Ewing-Like Sarcoma
Status:
Recruiting
Trial end date:
2024-03-02
Target enrollment:
Participant gender:
Summary
The purpose of this study is to find out whether LY2880070 combined with the chemotherapy
drug gemcitabine is an effective treatment for Ewing sarcoma or Ewing-like sarcoma.